Exome Asset Management LLC Replimune Group, Inc. Call Options Transaction History
Exome Asset Management LLC
- $112 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding REPL
# of Institutions
172Shares Held
78.5MCall Options Held
69.4KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$106 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$104 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA4.9MShares$46.9 Million5.02% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$45.1 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$37.4 Million9.21% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $472M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...